281 related articles for article (PubMed ID: 16513860)
1. A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders.
Reyes M; Buitelaar J; Toren P; Augustyns I; Eerdekens M
Am J Psychiatry; 2006 Mar; 163(3):402-10. PubMed ID: 16513860
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.
Aman MG; De Smedt G; Derivan A; Lyons B; Findling RL;
Am J Psychiatry; 2002 Aug; 159(8):1337-46. PubMed ID: 12153826
[TBL] [Abstract][Full Text] [Related]
3. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
Aman MG; Binder C; Turgay A
J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
[TBL] [Abstract][Full Text] [Related]
4. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Loy JH; Merry SN; Hetrick SE; Stasiak K
Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.
Turgay A; Binder C; Snyder R; Fisman S
Pediatrics; 2002 Sep; 110(3):e34. PubMed ID: 12205284
[TBL] [Abstract][Full Text] [Related]
6. Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ.
Findling RL; Aman MG; Eerdekens M; Derivan A; Lyons B;
Am J Psychiatry; 2004 Apr; 161(4):677-84. PubMed ID: 15056514
[TBL] [Abstract][Full Text] [Related]
7. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.
Research Units on Pediatric Psychopharmacology Autism Network
Am J Psychiatry; 2005 Jul; 162(7):1361-9. PubMed ID: 15994720
[TBL] [Abstract][Full Text] [Related]
8. Treating disruptive behavior disorders with risperidone: a 1-year, open-label safety study in children and adolescents.
Haas M; Karcher K; Pandina GJ
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):337-45. PubMed ID: 18759643
[TBL] [Abstract][Full Text] [Related]
9. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
Haas M; Delbello MP; Pandina G; Kushner S; Van Hove I; Augustyns I; Quiroz J; Kusumakar V
Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994
[TBL] [Abstract][Full Text] [Related]
10. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
[TBL] [Abstract][Full Text] [Related]
11. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.
Hirschfeld RM; Keck PE; Kramer M; Karcher K; Canuso C; Eerdekens M; Grossman F
Am J Psychiatry; 2004 Jun; 161(6):1057-65. PubMed ID: 15169694
[TBL] [Abstract][Full Text] [Related]
12. Cognitive function with long-term risperidone in children and adolescents with disruptive behavior disorder.
Pandina GJ; Zhu Y; Cornblatt B
J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):749-56. PubMed ID: 20035593
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities.
Buitelaar JK; van der Gaag RJ; Cohen-Kettenis P; Melman CT
J Clin Psychiatry; 2001 Apr; 62(4):239-48. PubMed ID: 11379837
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy of disruptive behavior and item changes on a standardized rating scale: pooled analysis of risperidone effects in children with subaverage IQ.
Aman M; Buitelaar J; Smedt GD; Wapenaar R; Binder C
J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):220-32. PubMed ID: 15910206
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently.
Macfadden W; Alphs L; Haskins JT; Turner N; Turkoz I; Bossie C; Kujawa M; Mahmoud R
Bipolar Disord; 2009 Dec; 11(8):827-39. PubMed ID: 19922552
[TBL] [Abstract][Full Text] [Related]
16. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.
Snyder R; Turgay A; Aman M; Binder C; Fisman S; Carroll A;
J Am Acad Child Adolesc Psychiatry; 2002 Sep; 41(9):1026-36. PubMed ID: 12218423
[TBL] [Abstract][Full Text] [Related]
17. Risperidone for the treatment of affective symptoms in children with disruptive behavior disorder: a post hoc analysis of data from a 6-week, multicenter, randomized, double-blind, parallel-arm study.
Biederman J; Mick E; Faraone SV; Wozniak J; Spencer T; Pandina G
Clin Ther; 2006 May; 28(5):794-800. PubMed ID: 16861101
[TBL] [Abstract][Full Text] [Related]
18. Risperidone and cognitive function in children with disruptive behavior disorders.
Pandina GJ; Bilder R; Harvey PD; Keefe RS; Aman MG; Gharabawi G
Biol Psychiatry; 2007 Aug; 62(3):226-34. PubMed ID: 17210137
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
Rezaei V; Mohammadi MR; Ghanizadeh A; Sahraian A; Tabrizi M; Rezazadeh SA; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1269-72. PubMed ID: 20637249
[TBL] [Abstract][Full Text] [Related]
20. Risperidone reduces aggression in boys with a disruptive behaviour disorder and below average intelligence quotient: analysis of two placebo-controlled randomized trials.
LeBlanc JC; Binder CE; Armenteros JL; Aman MG; Wang JS; Hew H; Kusumakar V
Int Clin Psychopharmacol; 2005 Sep; 20(5):275-83. PubMed ID: 16096518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
